Medicament for treating allergic rhinitis and preparation method thereof

Abstract

The invention belongs to the technical field of medicine, and particularly relates to a medicament for treating allergic rhinitis and a preparation method thereof, the sunscreen lotion comprises active zinc, physiological seawater, microcrystalline cellulose and purified water; according to the application, the nasal mucosa is repaired by compounding the PA with the active zinc, so that the allergic rhinitis is solved.

Description

Technical Field

[0001] The invention belongs to the field of medical technology, and specifically refers to a medicament for treating allergic rhinitis and a preparation method thereof. Background Art

[0002] Allergic rhinitis, also known as allergic rhinitis, is a common chronic disease with various causes, including genetic factors, environmental factors, food and drug factors, physical factors and climate change. The main symptoms of allergic rhinitis include nasal itching, paroxysmal sneezing, watery nasal discharge and nasal congestion, and the symptoms may occur seasonally or irregularly throughout the year. In some cases, patients may also experience eye symptoms such as itchy eyes, tearing, red and swollen eyes and burning sensation, as well as respiratory symptoms such as itchy throat, chest tightness, coughing, and asthma attacks.

[0003] Modern medicine has a detailed explanation of the pathogenesis of allergic rhinitis, believing that it is mainly a series of reactions involving IgE-mediated immune active cells and cytokines. For allergic rhinitis, modern medicine mainly uses antihistamines, glucocorticoids, anticholinergics and other drugs for treatment. These drugs can achieve certain therapeutic effects and relieve patients' symptoms. However, these drugs cannot completely cure allergic rhinitis, and long-term use may also produce significant side effects. Summary of the invention

[0004] In order to solve the problem that modern medicine mainly uses antihistamines, glucocorticoids, anticholinergic drugs and the like for treatment, these drugs can achieve certain therapeutic effects and relieve the symptoms of patients. However, these drugs cannot completely cure allergic rhinitis, and long-term use may also produce significant side effects. The present invention provides a therapeutic agent for allergic rhinitis and a preparation method thereof.

[0005] The technical solution adopted by the present invention is as follows: The present invention provides a therapeutic agent for allergic rhinitis, which consists of 1% to 5% by weight of active zinc, 40% to 98% by weight of physiological seawater, 0.5% to 3% of microcrystalline cellulose, and 40% to 90% by weight of purified water.

[0006] Furthermore, the medicament consists of 3% active zinc, 50% physiological seawater, 3% microcrystalline cellulose, and 44% purified water in weight percentage.

[0007] This scheme also discloses a method for preparing a medicament for treating allergic rhinitis, which mainly comprises the following steps: Step 1: Take purified water and put it into a clean container for later use; Step 2: Add microcrystalline cellulose to the container, stir while adding to ensure that the microcrystalline cellulose is evenly dispersed, and continue stirring until the microcrystalline cellulose is completely dissolved to form a uniform microcrystalline cellulose solution; Step 3: Pour the microcrystalline cellulose solution into a clean container; Step 4: Slowly add physiological seawater into a clean container, stirring while adding to ensure uniform mixing to obtain a mixed solution; Step 5: Slowly add active zinc into a clean container, stirring while adding, to obtain a medicine; Step 6: Take samples of the medicine for testing, and fill it after passing the inspection.

[0008] The beneficial effects achieved by the present invention using the above structure are as follows: This application solves allergic rhinitis by repairing the nasal mucosa through PA compound active zinc. DETAILED DESCRIPTION

[0009] The following are specific embodiments of the present invention, which further describe the technical solution of the present invention, but the protection scope of the present invention is not limited to these embodiments. Any changes or equivalent substitutions that do not deviate from the concept of the present invention are included in the protection scope of the present invention.

[0010] Example 1 A therapeutic agent for allergic rhinitis comprises 3% by weight of active zinc, 50% by weight of physiological seawater, 3% by weight of microcrystalline cellulose and 44% by weight of purified water.

[0011] A method for preparing a medicament for treating allergic rhinitis comprises the following steps: Step 1: Take purified water and put it into a clean container for later use; Step 2: Add microcrystalline cellulose to the container, stir while adding to ensure that the microcrystalline cellulose is evenly dispersed, and continue stirring until the microcrystalline cellulose is completely dissolved to form a uniform microcrystalline cellulose solution; Step 3: Pour the microcrystalline cellulose solution into a clean container; Step 4: Slowly add physiological seawater into a clean container, stirring while adding to ensure uniform mixing to obtain a mixed solution; Step 5: Slowly add active zinc into a clean container, stirring while adding, to obtain a medicine; Step 6: Take samples of the medicine for testing, and fill it after passing the inspection.

[0012] Example 2 A medicine for treating allergic rhinitis comprises 5% by weight of active zinc, 42% by weight of physiological seawater, 0.5% by weight of microcrystalline cellulose and 48% by weight of purified water.

[0013] A method for preparing a medicament for treating allergic rhinitis comprises the following steps: Step 1: Take purified water and put it into a clean container for later use; Step 2: Add microcrystalline cellulose to the container, stir while adding to ensure that the microcrystalline cellulose is evenly dispersed, and continue stirring until the microcrystalline cellulose is completely dissolved to form a uniform microcrystalline cellulose solution; Step 3: Pour the microcrystalline cellulose solution into a clean container; Step 4: Slowly add physiological seawater into a clean container, stirring while adding to ensure uniform mixing to obtain a mixed solution; Step 5: Slowly add active zinc into a clean container, stirring while adding, to obtain a medicine; Step 6: Take samples of the medicine for testing, and fill it after passing the inspection.

[0014] Example 3 A medicine for treating allergic rhinitis comprises 1% by weight of active zinc, 50% by weight of physiological seawater, 1% by weight of microcrystalline cellulose and 48% by weight of purified water.

[0015] A method for preparing a medicament for treating allergic rhinitis comprises the following steps: Step 1: Take purified water and put it into a clean container for later use; Step 2: Add microcrystalline cellulose to the container, stir while adding to ensure that the microcrystalline cellulose is evenly dispersed, and continue stirring until the microcrystalline cellulose is completely dissolved to form a uniform microcrystalline cellulose solution; Step 3: Pour the microcrystalline cellulose solution into a clean container; Step 4: Slowly add physiological seawater into a clean container, stirring while adding to ensure uniform mixing to obtain a mixed solution; Step 5: Slowly add active zinc into a clean container, stirring while adding, to obtain a medicine; Step 6: Take samples of the medicine for testing, and fill it after passing the inspection.

[0016] The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.

[0017] The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. A pharmaceutical composition for treating allergic rhinitis, characterized in that: The medicament comprises 1% to 5% active zinc, 40% to 98% physiological seawater, 0.5% to 3% microcrystalline cellulose, and 40% to 90% purified water in weight percentages.

2. The allergic rhinitis treatment agent according to claim 1, characterized in that: The medicine comprises 3% active zinc, 50% physiological seawater, 3% microcrystalline cellulose and 44% purified water in weight percentage.

3. A method for preparing a therapeutic agent for allergic rhinitis, wherein the therapeutic agent for allergic rhinitis according to claim 3 is characterized in that: The steps include: Step 1: Take purified water and put it into a clean container for later use; Step 2: Add microcrystalline cellulose to the container, stir while adding to ensure that the microcrystalline cellulose is evenly dispersed, and continue stirring until the microcrystalline cellulose is completely dissolved to form a uniform microcrystalline cellulose solution; Step 3: Pour the microcrystalline cellulose solution into a clean container; Step 4: Slowly add physiological seawater into a clean container, stirring while adding to ensure uniform mixing to obtain a mixed solution; Step 5: Slowly add active zinc into a clean container, stirring while adding, to obtain a medicine; Step 6: Take samples of the medicine for testing, and fill it after passing the inspection.